eMedicine Specialties > Emergency Medicine > Endocrine & Metabolic

Hypoglycemia

Author: Frank C Smeeks lll, MD, Chief Medical Officer, Frye Regional Medical Center
Contributor Information and Disclosures

Updated: Nov 26, 2008

Introduction

Background

Hypoglycemia is considered present when serum glucose level is less than 50 mg/dL. However, more specifically, it is defined as a decrease in the blood glucose level or its tissue utilization that results in demonstrable signs or symptoms. These signs or symptoms usually include altered mental status and/or sympathetic nervous system stimulation. The glucose level at which an individual becomes symptomatic is highly variable.

Pathophysiology

The organ systems that manifest the signs and symptoms of hypoglycemia are the central and autonomic nervous systems.

Hypoglycemia can be due to alimentary problems, idiopathic causes, fasting, insulinoma, endocrine problems, extrapancreatic causes, hepatic disease, and miscellaneous causes.

Mortality/Morbidity

Delay in treatment can result in profound sequelae, including death.

  • Acute sequelae include coma, cardiac dysrhythmia, and death.
  • The risk of permanent neurologic deficits increases with prolonged hypoglycemia; such deficits can include hemiparesis, memory impairment, diminished language skills, decreased abstract thinking capabilities, and ataxia.
  • Because the consequences of hypoglycemia can be devastating and an antidote is readily available, diagnosis and treatment must be rapid in any patient with suspected hypoglycemia, regardless of the cause.

Sex

Females are affected by hypoglycemia more than males.

Age

Hypoglycemia affects predominantly older adults.

Clinical

History

  • Patients often have a history of diabetes mellitus.
  • A history of insulin usage or ingestion of an oral hypoglycemic agent may be known, and possible toxic ingestion should be considered.
  • Inquire if the patient is taking any new medications.
  • Obtaining an accurate medical history may be difficult if the patient's mental status is altered.
  • The medical history may include diabetes mellitus, renal insufficiency/failure, alcoholism, hepatic cirrhosis/failure, other endocrine diseases, or recent surgery.
  • The patient's medication and drug history should be reviewed carefully for potential causes of hypoglycemia.
  • The social history may include ethanol intake and nutritional deficiency.
  • Review systems for weight reduction, fatigue, somnolence, nausea and vomiting, and headache.
  • Look for other symptoms suggesting infection.
  • Central nervous system
    • Headache
    • Confusion
    • Personality changes
  • Cardiovascular system - Palpitations
  • GI symptoms
    • Hunger
    • Nausea
    • Belching
  • Adrenergic symptoms
    • Sweating
    • Anxiety
    • Tremulousness
    • Nervousness

Physical

Physical findings are nonspecific in hypoglycemia and generally are related to the central and autonomic nervous systems.

  • Assess vital signs for hypothermia, tachypnea, tachycardia, hypertension, and bradycardia (neonates).
  • The head, eyes, ears, nose, and throat (HEENT) examination may indicate blurred vision, pupils normal to fixed and dilated, icterus (usually cholestatic due to hepatic disease), and parotid pain (due to endocrine causes).
  • Cardiovascular disturbances may include tachycardia (bradycardia in neonates), hypertension or hypotension, and dysrhythmias.
  • Respiratory disturbances may include dyspnea, tachypnea, and acute pulmonary edema.
  • GI disturbances may include nausea and vomiting, dyspepsia, and abdominal cramping.
  • Skin may be diaphoretic and warm or show signs of dehydration with decrease in turgor.
  • Neurologic conditions include coma, confusion, fatigue, loss of coordination, combative or agitated disposition, stroke syndrome, tremors, convulsions, and diplopia.

Causes

  • Causes of hypoglycemia are varied, but it is seen most often in diabetic patients.
  • Hypoglycemia may result from medication changes or overdoses, infection, diet changes, metabolic changes over time, or activity changes; however, no acute cause may be found.
  • Careful consideration should be given to all diabetic patients presenting with hypoglycemia. New medications, activity changes, and infection should be considered.
  • Early in the course of non–insulin-dependent diabetes, patients may experience episodes of hypoglycemia several hours after meals. The symptoms generally are brief and respond spontaneously.
  • Patients with no prior history of hypoglycemia require a complete workup to find a potentially treatable disease.
  • Drugs that may be related to hypoglycemia include the following: oral hypoglycemics, sulfonamide, phenylbutazone, insulin, bishydroxy coumarin, salicylates, p-aminobenzoic acid, propoxyphene, haloperidol, stanozolol, ethanol, hypoglycin, carbamate insecticide, disopyramide, isoniazid, methanol, methotrexate, pentamidine, sulfonamide, tricyclic antidepressants, cytotoxic agents, organophosphates, propranolol plus ethanol, didanosine, chlorpromazine, quinine, sulfa drugs, fluoxetine, sertraline, fenfluramine, trimethoprim, 6-mercaptopurine, thiazide diuretics, thioglycolate, tremetol, ritodrine, disodium ethylenediaminetetraacetic acid (EDTA), clofibrate, angiotensin converting enzyme (ACE) inhibitors, and lithium.
  • Factitious hypoglycemia or self-induced hypoglycemia can be seen in health care workers or in relatives who care for diabetic family members at home. Further discussion, including the diagnostic use of C-peptide levels and hemoglobin A1C, can be found in the articles Diabetes Mellitus, Type 1 - A Review and Diabetes Mellitus, Type 2 - A Review.
  • Other causes include the following:
    • GI surgery
    • Idiopathic
    • Hepatic disease
    • Islet cell tumor/extrapancreatic tumor
    • Exercise (in diabetic patients)
    • Pregnancy
    • Renal glycosuria
    • Ketotic hypoglycemia of childhood
    • Adrenal insufficiency
    • Hypopituitarism
    • Enzyme deficiency
    • Large tumors (eg, mesenchymal tumors, epithelial tumors, endothelial tumors)
    • Sepsis
    • Starvation
    • Artifact

More on Hypoglycemia

Overview: Hypoglycemia
Differential Diagnoses & Workup: Hypoglycemia
Treatment & Medication: Hypoglycemia
Follow-up: Hypoglycemia
References

References

  1. Altuntas Y, Bilir M, Ucak S, Gundogdu S. Reactive hypoglycemia in lean young women with PCOS and correlations with insulin sensitivity and with beta cell function. Eur J Obstet Gynecol Reprod Biol. Apr 1 2005;119(2):198-205. [Medline].

  2. Bourcigaux N, Arnault-Ouary G, Christol R, et al. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia. Clin Ther. Feb 2005;27(2):246-51. [Medline].

  3. Ellenhorn MJ, Barceloux DG. Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 1988:440-61.

  4. Goldfrank LR. Goldfrank's Toxicologic Emergencies. 1994:577-88.

  5. Haddad LM, Winchester JF. Clinical Management of Poisoning and Drug Overdose. 2nd ed. 1990:1475-6.

  6. Hoffman RS, Goldfrank LR. The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail'. JAMA. Aug 16 1995;274(7):562-9. [Medline].

  7. Kahn RC, Shechter Y. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Goodman and Gilman's: The Pharmacologic Basis of Therapeutics. 8th ed. 1993:1463-84.

  8. Leiken JB, Palouchek FP. Poisoning and Toxicology Handbook. 1996-1997.

  9. Martin FI, Hansen N, Warne GL. Attempted suicide by insulin overdose in insulin-requiring diabetics. Med J Aust. Jan 15 1977;1(3):58-60. [Medline].

  10. McEvoy GK. Drug Information. 1986.

  11. Paterson KR, Paice BJ, Lawson DH. Undesired effects of biguanide therapy. Adverse Drug React Acute Poisoning Rev. 1984;3(3):173-82. [Medline].

  12. Patrick AW, Williams G. Adverse effects of exogenous insulin. Clinical features, management and prevention. Drug Saf. Jun 1993;8(6):427-44. [Medline].

  13. Ragland G. Hypoglycemia. In: Tintinalli J, et al, eds. Emergency Medicine: A Comprehensive Study Guide. 1996:939-46.

Further Reading

Keywords

hypoglycemia, low blood sugar, low glucose, glucopenia, decrease in the blood glucose level, insulinoma, coma, cardiac dysrhythmia, confusion, convulsions, diabetes, non–insulin-dependent diabetes, oral hypoglycemics, islet cell tumor, extrapancreatic tumor,insulin, palpitations, nausea, sweating, anxiety, diabetes mellitus type 1, diabetes mellitus type 2

Contributor Information and Disclosures

Author

Frank C Smeeks lll, MD, Chief Medical Officer, Frye Regional Medical Center
Frank C Smeeks lll, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Physician Executives, American Medical Association, and North Carolina Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Robin R Hemphill, MD, MPH, Associate Professor, Director, Disaster Preparedness, Department of Emergency Medicine, Vanderbilt University Medical Center
Robin R Hemphill, MD, MPH is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Howard A Bessen, MD, Professor of Medicine, Department of Emergency Medicine, UCLA School of Medicine; Program Director, Harbor-UCLA Medical Center
Howard A Bessen, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.